Skull bones harbour immune cells that are poised to target brain tumours
Briefly

In this groundbreaking research, we demonstrate a novel therapeutic strategy that not only targets tumor cells directly but also modulates the immune environment to enhance antitumor immunity.
The implications of our findings suggest that the combined approach could lead to enhanced patient outcomes, particularly in those with advanced tumors that are difficult to treat.
Integrating these treatments may offer a dual benefit: reducing tumor burden while simultaneously preparing the immune system for a more robust attack against recurrences.
Furthermore, our analysis illuminates the potential for expanding the therapeutic index of existing drugs, ultimately allowing for more personalized treatment regimens tailored to patient needs.
Read at Nature
[
]
[
|
]